Rosiglitazone, medical reversal, and back to basics for diabetes.
作者信息
Prasad Vinay
机构信息
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
出版信息
Am Fam Physician. 2014 Sep 15;90(6):368, 370.
PMID:25251229
Abstract
摘要
相似文献
1
Rosiglitazone, medical reversal, and back to basics for diabetes.
Am Fam Physician. 2014 Sep 15;90(6):368, 370.
2
US regulators relax restrictions on rosiglitazone.
BMJ. 2013 Nov 28;347:f7144. doi: 10.1136/bmj.f7144.
3
FDA panel advises easing restrictions on rosiglitazone.
BMJ. 2013 Jun 10;346:f3769. doi: 10.1136/bmj.f3769.
4
How doctors practice evidence-based medicine.
J Eval Clin Pract. 2013 Feb;19(1):44-9. doi: 10.1111/j.1365-2753.2011.01765.x. Epub 2011 Aug 24.
5
Heart-stopping news. The diabetes drug Avandia is under fire: what you should know. Interview by Avery Comarow.
US News World Rep. 2007 Jun 4;142(20):64.
6
Efficacy and safety of a combination of metformin and rosiglitaone in patients with type 2 diabetes mellitus--a postmarketing study.
J Indian Med Assoc. 2003 Feb;101(2):113-4, 123.
7
In brief: rosiglitazone (Avandia) unbound.
Med Lett Drugs Ther. 2014 Feb 3;56(1435):12.
8
Thiazolidinediones in type 2 diabetes: a cardiology perspective.
Ann Pharmacother. 2008 Oct;42(10):1466-74. doi: 10.1345/aph.1K666. Epub 2008 Sep 2.
9
Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
Am J Ther. 2006 Sep-Oct;13(5):400-3. doi: 10.1097/01.mjt.0000208276.65249.1b.
10
[Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
MMW Fortschr Med. 2007 Aug 2;149(31-32):52-3.
引用本文的文献
1
Reversal and Remission of T2DM - An Update for Practitioners.
Vasc Health Risk Manag. 2022 Jun 14;18:417-443. doi: 10.2147/VHRM.S345810. eCollection 2022.
Zotero 插件